Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Rolziracetam → 5-[4-(3-Chloro-phenyl)-3-oxo-butyl]-pyrrolidin-2-one
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | Rolziracetam | HCID 71893 | — |
| 반응물 | HCID 178478996 | HCID 178478996 | — |
| 생성물 | 5-[4-(3-Chloro-phenyl)-3-oxo-butyl]-pyrrolidin-2-one | HCID 12970090 | 51.5% |
반응 단계
Analogous to the procedure described for Example 1A, Step A, tetrahydro-pyrrolizine-3,5-dione (2 g, 14 mmol) was reacted with 3-chlorobenzylmagnesium chloride (0.25M in Et2O, 62 mL, 15.5 mmol) over 2 h. Purification by medium pressure chromatography eluting with a solvent gradient (2:1 hexanes:EtOAc to EtOAc to 5% MeOH in CH2Cl2) provided 5-[4-(3-chloro-phenyl)-3-oxo-butyl]-pyrrolidin-2-one (1.9142 g). 1H NMR (CDCl3) δ7.27 (m, 2H), 7.19 (m, 1H), 7.08 (m, 1H), 6.27 (br, 1H), 3.68 (s, 2H), 3.60 (m, 1H), 2.52 (t, 2H), 2.29 (m, 2H), 2.21 (m, 1H), 1.88-1.60 (m, 3H); MS 266.2 (M+1), 264.2 (M−1).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US06747054B2 |
| 출처 데이터셋 | uspto-grants-2004_06 |
| ORD ID | ord-89253fb86b83492b8704725585a09c31 |
| 출처 메모 | uspto-grants-2004_06 |